Table 2.

Medical treatment in the study groups.

Medication	Group A (n = 71 (%))	Group B (n = 70 (%))	p-Value
ACE-I/ARA	48 (67.61%)	55(78.57%)	0.35
Beta-blockers	53 (74.65%)	62 (88.57%)	0.03
MRA	35 (49.30%)	50 (71.43%)	0.01
Diuretics (on discharge)	57 (80.28%)	63 (90.0%)	0.11
Ivabradine	3 (4.23%)	3 (4.29%)	0.69
Statin	48 (67.61%)	55 (78.57%)	0.14

ACE-I/ARA—angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor antagonists; MRA—mineralocorticoid receptor antagonists.